Potential health impacts of excessive flavonoid intake

https://doi.org/10.1016/S0891-5849(00)00304-XGet rights and content

Abstract

Plant flavonoids are common dietary components that have many potent biological properties. Early studies of these compounds investigated their mutagenic and genotoxic activity in a number of in vitro assays. Recently, a renewed interest in flavonoids has been fueled by the antioxidant and estrogenic effects ascribed to them. This has led to their proposed use as anticarcinogens and cardioprotective agents, prompting a dramatic increase in their consumption as dietary supplements. Unfortunately, the potentially toxic effects of excessive flavonoid intake are largely ignored. At higher doses, flavonoids may act as mutagens, pro-oxidants that generate free radicals, and as inhibitors of key enzymes involved in hormone metabolism. Thus, in high doses, the adverse effects of flavonoids may outweigh their beneficial ones, and caution should be exercised in ingesting them at levels above that which would be obtained from a typical vegetarian diet. The unborn fetus may be especially at risk, since flavonoids readily cross the placenta. More research on the toxicological properties of flavonoids is warranted given their increasing levels of consumption.

Introduction

Plant flavonoids are diphenylpropane derivatives that exert a wide range of biochemical and pharmacological effects. Their antioxidant properties [1], [2], cytostatic effects in tumorigenesis [3], and ability to inhibit a broad spectrum of enzymes, such as protein kinase C [4], tyrosine protein kinase [5], and topoisomerase II [6], [7], have led researchers to regard these compounds as potential anticarcinogens and cardioprotective agents. These findings have contributed to the dramatic increase in the consumption and use of dietary supplements containing high concentrations of plant flavonoids by some health-conscious individuals. Marketing strategies by manufacturers of flavonoid concentrates and herbal remedies advertise and often exaggerate their nontoxic therapeutic effects, most of which are not substantiated by regulated clinical trials. Furthermore, manufacturers’ recommended doses of these products might far exceed the flavonoid dose one could attain from a typical vegetarian diet. This, coupled with the common misconception that if a little of something is good then more is better, may result in individuals ingesting extremely high levels of these compounds.

Despite the apparently beneficial health effects of flavonoids, several studies indicate their mutagenicity and genotoxicity in both bacterial and mammalian experimental systems [8], [9], [10] (Table 1). This may be due to their activity as pro-oxidants [11], [12] in generating free radicals that damage DNA or their inhibition of DNA-associated enzymes such as topoisomerase. Unrepaired or misrepaired oxidative DNA damage can result in DNA strand breaks and mutations [13], [14] that may lead to irreversible preneoplastic lesions. Furthermore, high intakes of these compounds may potentiate other deleterious effects due to their diverse pharmacological properties, which may alter drug and amino acid metabolism, modulate the activity of environmental genotoxicants, and alter the activity of other key metabolizing enzymes. While there is ample evidence that a flavonoid-rich diet may promote good health and provide protection from age-related diseases, there remains uncertainty regarding the conditions and the levels of flavonoid intake necessary to pose a potential health hazard. Therefore, this review will seek to evaluate the potential toxicity of some of these compounds, particularly at levels higher than those generally found in a normal diet, but which may be attained through supplementation of plant extracts.

Section snippets

Characteristics and content of flavonoids in common foods

Flavonoids are widespread in nature, occurring in all plant families, and are found in considerable quantities in fruits, vegetables, grains, cola, tea, coffee, cocoa, beer, and red wine [15], [16], [17]. In the U.S., the daily dietary intake of mixed flavonoids is estimated to be in the range of 500 to 1000 mg [18], but can be as high as several grams in those supplementing their diets with flavonoids or flavonoid-containing herbal preparations such as ginkgo biloba, Pycnogenol 227 (Horphag

Metabolism and pharmacokinetics of flavonoids

Although the metabolism of flavonoids has not been well characterized, studies have shown that there is great variability in the preferential pathways among individuals [64], [65], which may be due to differences in gut microflora populations. Early studies considered flavonoids nonabsorbable due to their general occurrence as conjugates of sugars called glycosides [18]. Only free flavonoids called aglycones were thought to penetrate the intestinal wall. Complete degradation of flavonoids was

Mutagenicity and genotoxicity of flavonoids

Exposure to mutagenic or premutagenic agents in the diet is considered an important factor in the etiology of human cancers [76]. Early studies of flavonoids first documented the mutagenicity of quercetin [77], [78], [79] in its capacity to cause base-pair substitutions and frame-shift mutations in the Ames test, induce chromosomal aberrations and sister chromatid exchanges in CHO cells [80], and generate micronuclei in human lymphocytes in the absence and presence of activation [81], [82]

Flavonoids as topoisomerase inhibitors

The cytotoxic potential of many flavonoids may be due to their activity as topoisomerase II inhibitors. Genistein, biochanin A, equol, myricetin, and quercetin have been identified as potent topoisomerase II inhibitors at low concentrations, similar in activity to the epipodophylotoxins widely used in cancer therapy [6], [94], [95]. Topoisomerase II inhibitors cause an accumulation of enzyme-DNA covalent intermediates called cleavable complexes, that may lead to double-strand DNA lesions at

Effects on thyroid hormone production

Flavonoids decrease both iodide ion uptake and incorporation in animal studies [104], [105]. These data are consistent with the endemic goiter described in populations where flavone-concentrated millet is their main dietary staple [61], [63] and may explain thyroid disease described in soy-fed babies [106].

Studies by Divi et al. [107] showed that genistein, diadzein, quercetin, kaempferol, and naringenin inhibit thyroxine synthesis by acting as alternate substrates for tyrosine iodination,

Safe flavonoid intake

A number of epidemiological studies suggest that a decreased risk of heart disease and cancers of the breast [108], prostate [109], lung [110], colon [111], and stomach [112] is associated with increased consumption of fruits, vegetables, and soy products. Populations at lowest risk are Asians and vegetarians. Based on the average daily intake of flavonols (68 mg) and isoflavones (20–240 mg) in Asian populations, dietary exposures at these doses are not likely to cause adverse health effects.

Conclusion

A significant number of studies provide evidence that the biologic activities of flavonoids may play a dual role in mutagenesis and carcinogenesis. They can act as antimutagens/promutagens and antioxidants/pro-oxidants, which is largely dependent upon the levels consumed as well as the physiological conditions in the body. Exposure to increased levels of flavonoids, whether through the diet or by supplementation, may potentially overwhelm the system, leading to the formation of reactive oxygen

Acknowledgements

Supported by the National Foundation for Cancer Research.

References (112)

  • N.J. Miller et al.

    The antioxidant properties of theaflavins and their gallate esters—radical scavengers or metal chelators?

    FEBS Lett

    (1996)
  • M. Loukovaara et al.

    Regulation of sex hormone–binding globulin production by isoflavonoids and patterns of isoflavonoid conjugation in HepG2 cell cultures

    Steroids

    (1995)
  • W.M. Keung

    Dietary estrogenic isoflavones are potent inhibitors of β-hydroxysteroid dehydrogenase of P. testosteronii

    Biochem. Biophys. Res. Commun.

    (1995)
  • A. Okura et al.

    Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells

    Biochem. Biophys. Res. Commun.

    (1988)
  • P.D. Nesbitt et al.

    Human metabolism of mammalian lignan precursors in raw and processed flaxseed

    Amer. J. Clin. Nutr.

    (1999)
  • C. Wang et al.

    Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes

    J. Ster. Biochem. Molec. Biol.

    (1994)
  • J.C. Le Bail et al.

    Aromatase and 17β-hydroxysteroid dehydrogenase inhibition by flavonoids

    Cancer Lett

    (1998)
  • H. Sartelet et al.

    Flavonoids extracted from fonio millet (Digitaria exilis) reveal potent antithyroid properties

    Nutrition

    (1996)
  • G.E. Joannou et al.

    A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids

    J. Ster. Biochem. Molec. Biol.

    (1995)
  • M.K. Piskula et al.

    Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues

    J. Nutr.

    (1998)
  • C. Manach et al.

    Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties

    FEBS Lett

    (1998)
  • B.T. Zhu et al.

    Catechol-O-methyltransferase–catalyzed rapid O-methylation of mutagenic flavonoids. Metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo

    J. Biol. Chem.

    (1994)
  • C. Manach et al.

    Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin

    J. Nutr.

    (1995)
  • H. Adlercreutz et al.

    Maternal and neonatal phytoestrogens in Japanese women during birth

    Amer. J. Obstetr. Gynecol.

    (1999)
  • J.T. MacGregor et al.

    Mutagenicity of plant flavonoidsstructural requirements for mutagenic activity in Salmonella typhimurium

    Mutat. Res.

    (1978)
  • J.P. Brown et al.

    Mutagenicity of plant flavonols in the Salmonella/mammalian microsome testactivation of flavonol glycosides by mixed glycosidases from rat cecal bacteria and other sources

    Mutat. Res.

    (1979)
  • J.H. Carver et al.

    Genetic effects of the flavonols quercetin, kaempferol, and galangin on Chinese hamster ovary cells in vitro

    Mutat. Res.

    (1983)
  • H. Caria et al.

    Genotoxicity of quercetin in the micronucleus assay in mouse bone marrow erythrocytes, human lymphocytes, V79 cell line, and identification of kinetochore-containing (CREST staining) micronuclei in human lymphocytes

    Mutat. Res.

    (1995)
  • W.F. Hodnick et al.

    Inhibition of mitochondrial respiration and production of toxic oxygen radicals by flavonoids. A structure-activity study

    Biochem. Pharmacol.

    (1986)
  • R.D. Olson et al.

    Mechanism of adriamycin cardiotoxicityevidence for oxidative stress

    Life Sci

    (1981)
  • C.A. Pritsos et al.

    Involvement of superoxide in the interaction of 2,3-dichloro-1,4-naphthoquinone with mitochondrial membranes

    Arch. Biochem. Biophys.

    (1982)
  • C.A. Pritsos et al.

    A redox cycling mechanism of action for 2,3-dichloro-1,4-naphthoquinone with mitochondrial membranes and the role of sulfhydryl groups

    Biochem. Pharmacol.

    (1984)
  • S.C. Sahu et al.

    Interactions of flavonoids, trace metals, and oxygennuclear DNA damage and lipid peroxidation induced by myricetin

    Cancer Lett

    (1993)
  • S.C. Sahu et al.

    Pro-oxidant activity of flavonoidseffects on glutathione and glutathione-S transferase in isolated rat liver nuclei

    Cancer Lett

    (1996)
  • T. Chan et al.

    Oxygen activation during peroxidase catalyzed metabolism of flavones or flavanones

    Chem.-Biol. Interact.

    (1999)
  • G. Cimino et al.

    ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy

    Blood

    (1993)
  • R.L. Prior et al.

    Antioxidant capacity and polyphenolic components of teasimplications for altering in vivo antioxidant status

    Proc. Soc. Exper. Biol. Med.

    (1999)
  • A.H. Conney et al.

    Inhibitory effect of green and black tea on tumor growth

    Proc. Soc. Exper. Biol. Med.

    (1999)
  • A. Komori et al.

    Anticarcinogenic activity of green tea polyphenols

    Japan. J. Clin. Oncol.

    (1993)
  • C.A. Austin et al.

    Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives

    Biochem. J.

    (1992)
  • A. Constantinou et al.

    Flavonoids as DNA topoisomerase antagonists and poisonsstructure-activity relationships

    J. Natural Prod.

    (1995)
  • S. Suzuki et al.

    Quercetin induces recombinational mutations in cultured cells as detected by DNA fingerprinting

    Japan. J. Cancer Res.

    (1991)
  • J. Jurado et al.

    Study on the mutagenic activity of 13 bioflavonoids with the Salmonella Ara test

    Mutagenesis

    (1991)
  • E. Dickancaité et al.

    Pro-oxidant character of flavonoid cytotoxicitystructure-activity relationships

    Biochem. Molec. Biol. Int.

    (1998)
  • L.H. Breimer

    Molecular mechanisms of oxygen radical carcinogenesis and mutagenesisthe role of DNA base damage

    Molec. Carcinogen.

    (1990)
  • G. Hertog et al.

    Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands

    J. Agric. Food Chem.

    (1992)
  • M.G. Hertog et al.

    Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands

    Nutr. Cancer

    (1993)
  • J. Kühnau

    The flavonoids. A class of semi-essential food componentstheir role in human nutrition

    World Rev. Nutr. Dietetics

    (1976)
  • J.B. Harborne et al.

    The flavonoids, vol. part 1

    (1975)
  • J.B. Harborne et al.

    The flavonoids, vol. part 2

    (1975)
  • Cited by (441)

    • Phytonutrients: adverse drug reactions

      2023, Phytonutrients and Neurological Disorders: Therapeutic and Toxicological Aspects
    View all citing articles on Scopus
    View full text